DK2632550T3 - METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA - Google Patents

METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA Download PDF

Info

Publication number
DK2632550T3
DK2632550T3 DK11837249.9T DK11837249T DK2632550T3 DK 2632550 T3 DK2632550 T3 DK 2632550T3 DK 11837249 T DK11837249 T DK 11837249T DK 2632550 T3 DK2632550 T3 DK 2632550T3
Authority
DK
Denmark
Prior art keywords
crofelemer
hiv
day
per day
individual
Prior art date
Application number
DK11837249.9T
Other languages
Danish (da)
English (en)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2632550(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Application granted granted Critical
Publication of DK2632550T3 publication Critical patent/DK2632550T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK11837249.9T 2010-10-31 2011-10-31 METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA DK2632550T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Publications (1)

Publication Number Publication Date
DK2632550T3 true DK2632550T3 (en) 2017-08-07

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11837249.9T DK2632550T3 (en) 2010-10-31 2011-10-31 METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA

Country Status (20)

Country Link
US (4) US8962680B2 (cg-RX-API-DMAC7.html)
EP (1) EP2632550B1 (cg-RX-API-DMAC7.html)
JP (2) JP6063385B2 (cg-RX-API-DMAC7.html)
CN (2) CN107595836A (cg-RX-API-DMAC7.html)
AU (1) AU2011320155B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013010774A2 (cg-RX-API-DMAC7.html)
CA (1) CA2816416C (cg-RX-API-DMAC7.html)
DK (1) DK2632550T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012650A (cg-RX-API-DMAC7.html)
ES (1) ES2635435T3 (cg-RX-API-DMAC7.html)
HK (1) HK1249036A1 (cg-RX-API-DMAC7.html)
HU (1) HUE035393T2 (cg-RX-API-DMAC7.html)
MX (1) MX348184B (cg-RX-API-DMAC7.html)
PE (1) PE20140036A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500857A1 (cg-RX-API-DMAC7.html)
PL (1) PL2632550T3 (cg-RX-API-DMAC7.html)
PT (1) PT2632550T (cg-RX-API-DMAC7.html)
RU (1) RU2597746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012058664A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201303136B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
EP2015639A4 (en) 2006-05-01 2009-11-25 Napo Pharmaceuticals Inc METHOD FOR TREATING CONSTITUTIONAL PREDOMINANT IRRITATION SYNDROME
WO2007130893A2 (en) * 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
HUE035393T2 (en) 2010-10-31 2018-05-02 Napo Pharmaceuticals Inc Procedures and preparations for the treatment of HIV-related diarrhea
US20140163096A1 (en) * 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
JOP20220339A1 (ar) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc طرق وتركيبات علاج الإسهال الناتج عن العلاج الكيميائي
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP2255661A3 (en) 1996-10-16 2010-12-22 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
EP1937655A1 (en) * 2005-06-22 2008-07-02 University of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
JP2009524585A (ja) 2005-12-15 2009-07-02 バイエル・ヘルスケア・アクチェンゲゼルシャフト ウイルス感染を処置するためのジアリールウレア
EP2015639A4 (en) * 2006-05-01 2009-11-25 Napo Pharmaceuticals Inc METHOD FOR TREATING CONSTITUTIONAL PREDOMINANT IRRITATION SYNDROME
WO2007130893A2 (en) 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
PH12012500557A1 (en) 2009-08-26 2012-10-22 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
CA2777214A1 (en) * 2009-10-06 2011-04-14 The Regents Of The University Of California Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
HUE035393T2 (en) 2010-10-31 2018-05-02 Napo Pharmaceuticals Inc Procedures and preparations for the treatment of HIV-related diarrhea
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
MX2014007635A (es) 2011-12-22 2014-09-22 Glenmark Pharmaceuticals Ltd Composicion farmaceutica no enterica que comprende crofelemer.
US20140163096A1 (en) 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea

Also Published As

Publication number Publication date
BR112013010774A2 (pt) 2017-03-21
AU2011320155B2 (en) 2016-02-25
CA2816416C (en) 2020-02-11
US8962680B2 (en) 2015-02-24
AU2011320155A1 (en) 2013-05-09
ES2635435T3 (es) 2017-10-03
PL2632550T3 (pl) 2017-10-31
HK1249036A1 (zh) 2018-10-26
PT2632550T (pt) 2017-08-02
MX2013004873A (es) 2013-08-21
EP2632550B1 (en) 2017-05-03
ZA201303136B (en) 2016-01-27
PE20140036A1 (es) 2014-01-31
EP2632550A1 (en) 2013-09-04
ECSP13012650A (es) 2013-10-31
JP6310971B2 (ja) 2018-04-11
US20120184605A1 (en) 2012-07-19
RU2013123794A (ru) 2014-12-10
JP2017019806A (ja) 2017-01-26
WO2012058664A1 (en) 2012-05-03
CA2816416A1 (en) 2012-05-03
PH12013500857A1 (en) 2018-01-17
US20140294903A1 (en) 2014-10-02
JP2013540826A (ja) 2013-11-07
EP2632550A4 (en) 2014-04-23
HUE035393T2 (en) 2018-05-02
US20150190367A1 (en) 2015-07-09
RU2597746C2 (ru) 2016-09-20
US20120107370A1 (en) 2012-05-03
JP6063385B2 (ja) 2017-01-18
CN107595836A (zh) 2018-01-19
US9585868B2 (en) 2017-03-07
CN103370101A (zh) 2013-10-23
MX348184B (es) 2017-06-02

Similar Documents

Publication Publication Date Title
DK2632550T3 (en) METHODS AND COMPOSITIONS FOR TREATING HIV-ASSOCIATED DIARRIA
JP6159084B2 (ja) 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
US20140163096A1 (en) Methods and compositions for treating hiv-associated diarrhea
EP3592427A1 (fr) Prevention des risques associes à un allongement de l'intervalle qt d'origine medicamenteuse à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale
US20120270951A1 (en) Novel anti-inflammatory cyclooxygenase inhibitors
US11857510B2 (en) Methods and compositions for treating congenital diarrhea disorder
HK1183263A (en) Methods and compositions for treating hiv-associated diarrhea
HK1183263B (en) Methods and compositions for treating hiv-associated diarrhea
CN112789052A (zh) 用于保护皮肤免受紫外线辐射的番茄红素组合物和方法
WO2022115481A1 (en) Methods and compositions for treating post-acute infection gastrointestinal disorders
Marbury et al. Pharmacokinetics and safety of a single oral dose of once‐daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment
HK40016516A (en) Compositions for use in treating congenital diarrhea disorder
HK40048453A (en) Lycopene compositions and methods for protecting skin against ultraviolet radiation